Table 3.
Case | SV (mL) | EF (%) | EF (pp) | AT (%) | IT (%) |
---|---|---|---|---|---|
Control | 21.93 | 31.53 | 0 | 0 | 0 |
PVI | 18.61 | 27.73 | 3.80 | 8.67 | 14.30 |
PVI + BL | 15.22 | 22.55 | 8.97 | 12.18 | 28.96 |
PVI + AL | 17.41 | 26.18 | 5.34 | 11.22 | 17.69 |
PVI + AL + BL | 13.31 | 20.09 | 11.43 | 14.72 | 32.35 |
PVI + AL + RL | 16.58 | 25.13 | 6.39 | 13.31 | 20.28 |
PVI + MIL | 18.91 | 28.07 | 3.45 | 10.03 | 16.10 |
PVI + MIL + BL | 14.99 | 22.31 | 9.21 | 13.53 | 30.76 |
PVI + MIL + RL | 18.19 | 27.18 | 4.35 | 12.12 | 18.68 |
PVI + RL | 18.38 | 27.34 | 4.18 | 10.76 | 16.88 |
pp Percentage points, SV stroke volume, EF ejection fraction, AT ablated tissue, IT inactive tissue